|
G |
Abcb1b |
ATP-binding cassette, subfamily B (MDR/TAP), member 1B |
decreases expression |
EXP |
Dimethylformamide results in decreased expression of ABCB1B mRNA |
CTD |
PMID:12883083 |
|
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression |
ISO |
Thiocarbamates analog inhibits the reaction [Dimethylformamide results in increased expression of BAX protein] |
CTD |
PMID:29984871 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
multiple interactions increases expression |
EXP ISO |
[Dimethylformamide co-treated with Carbon Tetrachloride] results in decreased expression of BCL2L1 protein Dimethylformamide results in increased expression of BCL2L1 protein Thiocarbamates analog inhibits the reaction [Dimethylformamide results in decreased expression of BCL2L1 protein] |
CTD |
PMID:20097184 PMID:29984871 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases expression |
EXP ISO |
[Dimethylformamide co-treated with Carbon Tetrachloride] results in increased activity of CASP3 protein Dimethylformamide results in increased expression of CASP3 protein modified form CAT protein inhibits the reaction [Dimethylformamide results in increased expression of CASP3 protein modified form]; Thiocarbamates analog inhibits the reaction [Dimethylformamide results in increased expression of CASP3 protein modified form] |
CTD |
PMID:20097184 PMID:29984871 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases expression |
ISO |
CAT protein inhibits the reaction [Dimethylformamide results in increased expression of CASP9 protein modified form]; Thiocarbamates analog inhibits the reaction [Dimethylformamide results in increased expression of CASP9 protein modified form] |
CTD |
PMID:29984871 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions |
ISO |
CAT protein inhibits the reaction [Dimethylformamide results in increased expression of CASP3 protein modified form]; CAT protein inhibits the reaction [Dimethylformamide results in increased expression of CASP9 protein modified form]; CAT protein inhibits the reaction [Dimethylformamide results in increased expression of TP53 protein] |
CTD |
PMID:29984871 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
affects metabolic processing increases response to substance increases abundance multiple interactions increases expression increases oxidation increases metabolic processing |
ISO EXP |
CYP2E1 protein polymorphism affects the metabolism of Dimethylformamide CYP2E1 protein results in increased susceptibility to Dimethylformamide CYP2E1 polymorphism results in increased abundance of Dimethylformamide metabolite CYP2E1 protein affects the reaction [Dimethylformamide results in increased activity of GPT protein]; CYP2E1 protein affects the reaction [Dimethylformamide results in increased expression of HSP90B1 protein] Dimethylformamide results in increased expression of CYP2E1 protein CYP2E1 protein results in increased oxidation of Dimethylformamide CYP2E1 protein affects the metabolism of Dimethylformamide CYP2E1 protein results in increased metabolism of Dimethylformamide |
CTD |
PMID:9817075 PMID:10207612 PMID:11305777 PMID:15772367 PMID:29984871 PMID:31501917 More...
|
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions |
EXP |
[Dimethylformamide co-treated with Carbon Tetrachloride] results in increased expression of DDIT3 mRNA |
CTD |
PMID:20097184 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
multiple interactions |
EXP |
[Dimethylformamide co-treated with Carbon Tetrachloride] results in increased expression of EIF2AK3 protein modified form |
CTD |
PMID:20097184 |
|
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions increases activity |
ISO |
CYP2E1 protein affects the reaction [Dimethylformamide results in increased activity of GPT protein] |
CTD |
PMID:31501917 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gsr |
glutathione-disulfide reductase |
decreases expression |
EXP |
Dimethylformamide results in decreased expression of GSR mRNA |
CTD |
PMID:12883083 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
H2ax |
H2A.X variant histone |
increases expression |
ISO |
Dimethylformamide results in increased expression of H2AX protein |
CTD |
PMID:26387567 |
|
NCBI chr 8:44,671,927...44,673,257
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions decreases expression |
ISO |
Alitretinoin inhibits the reaction [Dimethylformamide results in decreased expression of HMOX1 protein]; U 0126 inhibits the reaction [Dimethylformamide results in decreased expression of HMOX1 protein] Dimethylformamide results in decreased expression of HMOX1 mRNA; Dimethylformamide results in decreased expression of HMOX1 protein |
CTD |
PMID:31875996 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hsp90b1 |
heat shock protein 90 beta family member 1 |
multiple interactions increases expression |
EXP ISO |
[Dimethylformamide co-treated with Carbon Tetrachloride] results in increased expression of HSP90B1 protein Dimethylformamide results in increased expression of HSP90B1 protein CYP2E1 protein affects the reaction [Dimethylformamide results in increased expression of HSP90B1 protein] |
CTD |
PMID:20097184 PMID:31501917 |
|
NCBI chr 7:21,110,431...21,124,762
Ensembl chr 7:21,110,457...21,124,788
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
multiple interactions |
EXP |
[Dimethylformamide co-treated with Carbon Tetrachloride] results in increased expression of HSPA5 mRNA; [Dimethylformamide co-treated with Carbon Tetrachloride] results in increased expression of HSPA5 protein |
CTD |
PMID:20097184 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Ltf |
lactotransferrin |
increases expression |
ISO |
Dimethylformamide results in increased expression of LTF mRNA |
CTD |
PMID:18063697 |
|
NCBI chr 8:110,999,948...111,022,795
Ensembl chr 8:110,999,948...111,022,795
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions increases phosphorylation |
ISO |
U 0126 inhibits the reaction [Dimethylformamide results in increased phosphorylation of MAPK1 protein] [Dimethylformamide results in increased phosphorylation of MAPK1 protein] which results in increased phosphorylation of RXRA protein; Dimethylformamide results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:31875996 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
increases phosphorylation multiple interactions |
ISO |
[Dimethylformamide results in increased phosphorylation of MAPK3 protein] which results in increased phosphorylation of RXRA protein; Dimethylformamide results in increased phosphorylation of MAPK3 protein U 0126 inhibits the reaction [Dimethylformamide results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:31875996 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mpo |
myeloperoxidase |
increases expression |
ISO |
Dimethylformamide results in increased expression of MPO mRNA |
CTD |
PMID:18063697 |
|
NCBI chr10:72,594,458...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Mre11 |
MRE11 homolog, double strand break repair nuclease |
increases expression |
ISO |
Dimethylformamide results in increased expression of MRE11 mRNA; Dimethylformamide results in increased expression of MRE11 protein |
CTD |
PMID:26387567 |
|
NCBI chr 8:11,618,876...11,680,451
Ensembl chr 8:11,632,354...11,678,279
|
|
G |
Ncf1 |
neutrophil cytosolic factor 1 |
increases expression |
ISO |
Dimethylformamide results in increased expression of NCF1 mRNA |
CTD |
PMID:18063697 |
|
NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
|
|
G |
Nefh |
neurofilament heavy chain |
affects expression |
EXP |
Dimethylformamide affects the expression of NEFH mRNA |
CTD |
PMID:22954530 |
|
NCBI chr14:79,830,362...79,840,347
Ensembl chr14:79,830,362...79,840,351
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions decreases activity |
ISO |
Alitretinoin inhibits the reaction [Dimethylformamide results in decreased activity of NFE2L2 protein]; Dimethylformamide promotes the reaction [NFE2L2 protein binds to RXRA protein]; U 0126 inhibits the reaction [Dimethylformamide results in decreased activity of NFE2L2 protein] |
CTD |
PMID:31875996 |
|
NCBI chr 3:60,594,239...60,621,785
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions decreases expression |
ISO |
Alitretinoin inhibits the reaction [Dimethylformamide results in decreased expression of NQO1 protein]; U 0126 inhibits the reaction [Dimethylformamide results in decreased expression of NQO1 protein] Dimethylformamide results in decreased expression of NQO1 mRNA; Dimethylformamide results in decreased expression of NQO1 protein |
CTD |
PMID:31875996 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
EXP |
[Dimethylformamide co-treated with Carbon Tetrachloride] results in increased cleavage of PARP1 protein |
CTD |
PMID:20097184 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Rad50 |
RAD50 double strand break repair protein |
increases expression |
ISO |
Dimethylformamide results in increased expression of RAD50 mRNA; Dimethylformamide results in increased expression of RAD50 protein |
CTD |
PMID:26387567 |
|
NCBI chr10:37,809,353...37,861,309
Ensembl chr10:37,808,726...37,861,396
|
|
G |
Rad51 |
RAD51 recombinase |
increases expression |
ISO |
Dimethylformamide results in increased expression of RAD51 mRNA; Dimethylformamide results in increased expression of RAD51 protein |
CTD |
PMID:26387567 |
|
NCBI chr 3:106,099,753...106,125,038
Ensembl chr 3:106,100,381...106,125,035
|
|
G |
Rxra |
retinoid X receptor alpha |
decreases degradation multiple interactions increases phosphorylation |
ISO |
Dimethylformamide results in decreased degradation of RXRA protein Alitretinoin inhibits the reaction [Dimethylformamide results in decreased degradation of RXRA protein]; Dimethylformamide promotes the reaction [NFE2L2 protein binds to RXRA protein]; U 0126 inhibits the reaction [Dimethylformamide results in decreased degradation of RXRA protein] [Dimethylformamide results in increased phosphorylation of MAPK1 protein] which results in increased phosphorylation of RXRA protein; [Dimethylformamide results in increased phosphorylation of MAPK3 protein] which results in increased phosphorylation of RXRA protein |
CTD |
PMID:31875996 |
|
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
|
|
G |
Sod1 |
superoxide dismutase 1 |
increases expression |
ISO |
Dimethylformamide results in increased expression of SOD1 mRNA |
CTD |
PMID:35238128 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sult1a1 |
sulfotransferase family 1A member 1 |
multiple interactions |
ISO |
Dimethylformamide inhibits the reaction [SULT1A1 protein results in increased sulfation of 1-hydroxypyrene]; Dimethylformamide inhibits the reaction [SULT1A1 protein results in increased sulfation of 4-nitrophenol] |
CTD |
PMID:14570759 |
|
NCBI chr 1:181,272,022...181,276,750
Ensembl chr 1:181,272,023...181,275,562
|
|
G |
Sult2a1 |
sulfotransferase family 2A member 1 |
multiple interactions |
ISO |
Dimethylformamide inhibits the reaction [SULT2A1 protein results in increased sulfation of 1-hydroxypyrene] |
CTD |
PMID:14570759 |
|
NCBI chr 1:75,451,178...75,508,142
Ensembl chr 1:74,911,100...75,508,134
|
|
G |
Tnfsf10 |
TNF superfamily member 10 |
increases expression |
ISO |
Dimethylformamide results in increased expression of TNFSF10 mRNA; Dimethylformamide results in increased expression of TNFSF10 protein |
CTD |
PMID:18063697 |
|
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions increases expression |
ISO |
CAT protein inhibits the reaction [Dimethylformamide results in increased expression of TP53 protein]; Thiocarbamates analog inhibits the reaction [Dimethylformamide results in increased expression of TP53 protein] Dimethylformamide results in increased expression of TP53 protein modified form |
CTD |
PMID:29984871 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Trim28 |
tripartite motif-containing 28 |
decreases expression |
ISO |
Dimethylformamide results in decreased expression of TRIM28 mRNA |
CTD |
PMID:35238128 |
|
NCBI chr 1:73,652,441...73,659,388
Ensembl chr 1:73,652,709...73,659,380
|
|
G |
Xrcc2 |
X-ray repair cross complementing 2 |
increases expression affects expression |
ISO |
Dimethylformamide results in increased expression of XRCC2 protein Dimethylformamide affects the expression of XRCC2 mRNA |
CTD |
PMID:26387567 |
|
NCBI chr 4:9,423,873...9,502,980
Ensembl chr 4:9,423,898...9,442,482
|
|
G |
Xrcc3 |
X-ray repair cross complementing 3 |
increases expression |
ISO |
Dimethylformamide results in increased expression of XRCC3 mRNA; Dimethylformamide results in increased expression of XRCC3 protein |
CTD |
PMID:26387567 |
|
NCBI chr 6:130,863,405...130,873,765
Ensembl chr 6:130,863,959...130,872,444
|
|
G |
Zp2 |
zona pellucida glycoprotein 2 |
increases expression |
ISO |
Dimethylformamide results in increased expression of ZP2 mRNA |
CTD |
PMID:35238128 |
|
NCBI chr 1:174,513,507...174,525,288
Ensembl chr 1:174,513,511...174,525,288
|
|